Logo

Ribavirin Combination Therapy of Chronic Hepatitis C Patients with End Stage Renal Disease: Review of Evidences on Efficacy and Safety

Author(s):
Seyed Moayed AlavianSeyed Moayed AlavianSeyed Moayed Alavian ORCID1,*, Vahid TabatabaeeVahid Tabatabaee2, Kamran Bagheri LankaraniKamran Bagheri Lankarani3
1Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, Tehran Hepatitis Center, alavian@thc.ir, Tehran, IR.Iran
2Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, Tehran Hepatitis Center, Tehran, IR.Iran
3Shiraz University of Medical Sciences, Fars, IR.Iran


Nephro-Urology Monthly:Vol. 3, issue 1; 1-7
Article type:Review Article
Received:Jun 06, 2010
Accepted:Jul 10, 2010
How to Cite:Seyed Moayed AlavianVahid TabatabaeeKamran Bagheri LankaraniRibavirin Combination Therapy of Chronic Hepatitis C Patients with End Stage Renal Disease: Review of Evidences on Efficacy and Safety.Nephro-Urol Mon.3(1):1-7.

Abstract

Full Text

Full text is available in PDF

comments

Leave a comment here

Share on
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles